Another recent study has reported that immune checkpoint ligands (e.g., PD-1, PD-L1, and CTLA-4) are strongly expressed in the tumor microenvironment of mismatch repair-deficient malignancies. The gene discussed is PDCD1; the disease is neoplasm.